187 related articles for article (PubMed ID: 9846276)
1. [Behavioral and neurochemical study on the role of the brain cholecystokinin system in anxiety].
Izumi T
Hokkaido Igaku Zasshi; 1998 Sep; 73(5):463-73. PubMed ID: 9846276
[TBL] [Abstract][Full Text] [Related]
2. Effect of the selective CCKB receptor antagonist LY288513 on conditioned fear stress in rats.
Izumi T; Inoue T; Tsuchiya K; Hashimoto S; Ohmori T; Koyama T
Eur J Pharmacol; 1996 Apr; 300(1-2):25-31. PubMed ID: 8741161
[TBL] [Abstract][Full Text] [Related]
3. [Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158].
Tsutsumi T; Isogawa K; Kouno Y; Hikichi T; Nagayama H; Akiyoshi J
Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Feb; 18(1):15-8. PubMed ID: 9592807
[TBL] [Abstract][Full Text] [Related]
4. Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158.
Tsutsumi T; Akiyoshi J; Isogawa K; Kohno Y; Hikichi T; Nagayama H
Neuropeptides; 1999 Dec; 33(6):483-6. PubMed ID: 10657528
[TBL] [Abstract][Full Text] [Related]
5. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
[TBL] [Abstract][Full Text] [Related]
6. [Effects of conditioned fear stress on monoaminergic systems in the rat brain].
Inoue T
Hokkaido Igaku Zasshi; 1993 May; 68(3):377-90. PubMed ID: 7686527
[TBL] [Abstract][Full Text] [Related]
7. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
[TBL] [Abstract][Full Text] [Related]
8. Suppression of conditioned fear by administration of CCKB receptor antisense oligodeoxynucleotide into the lateral ventricle.
Tsutsumi T; Akiyoshi J; Hikichi T; Kiyota A; Kohno Y; Katsuragi S; Yamamoto Y; Isogawa K; Nagayama H
Pharmacopsychiatry; 2001 Nov; 34(6):232-7. PubMed ID: 11778143
[TBL] [Abstract][Full Text] [Related]
9. Chronic stimulation of corticotropin-releasing factor receptor 1 enhances the anxiogenic response of the cholecystokinin system.
Sherrin T; Todorovic C; Zeyda T; Tan CH; Wong PT; Zhu YZ; Spiess J
Mol Psychiatry; 2009 Mar; 14(3):291-307. PubMed ID: 18195718
[TBL] [Abstract][Full Text] [Related]
10. Suppression of conditioned fear by administration of CRF receptor antagonist CP-154,526.
Hikichi T; Akiyoshi J; Yamamoto Y; Tsutsumi T; Isogawa K; Nagayama H
Pharmacopsychiatry; 2000 Sep; 33(5):189-93. PubMed ID: 11071021
[TBL] [Abstract][Full Text] [Related]
11. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
[TBL] [Abstract][Full Text] [Related]
12. CCKB receptors mediate CCK-8S-induced activation of dorsal hippocampus CA3 pyramidal neurons: an in vivo electrophysiological study in the rat.
Gronier B; Debonnel G
Synapse; 1995 Oct; 21(2):158-68. PubMed ID: 8584977
[TBL] [Abstract][Full Text] [Related]
13. CR 2945: a novel CCKB receptor antagonist with anxiolytic-like activity.
Revel L; Mennuni L; Garofalo P; Makovec F
Behav Pharmacol; 1998 May; 9(3):183-94. PubMed ID: 9832933
[TBL] [Abstract][Full Text] [Related]
14. Behavioral, central monoaminergic and hypothalamo-pituitary-adrenal axis correlates of fear-conditioned analgesia in rats.
Finn DP; Jhaveri MD; Beckett SR; Madjd A; Kendall DA; Marsden CA; Chapman V
Neuroscience; 2006; 138(4):1309-17. PubMed ID: 16426764
[TBL] [Abstract][Full Text] [Related]
15. Cholecystokinin-induced satiety is mediated through interdependent cooperation of CCK-A and 5-HT3 receptors.
Hayes MR; Savastano DM; Covasa M
Physiol Behav; 2004 Sep; 82(4):663-9. PubMed ID: 15327914
[TBL] [Abstract][Full Text] [Related]
16. The CCK-system mediates adaptation to novelty-induced stress in the rat: a pharmacological evidence.
Ballaz SJ; Akil H; Watson SJ
Neurosci Lett; 2007 Nov; 428(1):27-32. PubMed ID: 17950531
[TBL] [Abstract][Full Text] [Related]
17. Parasympathetic non-adrenergic, non-cholinergic transmission in rat parotid glands: effects of cholecystokinin-A and -B receptor antagonists on the secretory response.
Ekström J; Cevik Aras H
Regul Pept; 2008 Feb; 146(1-3):278-84. PubMed ID: 18006087
[TBL] [Abstract][Full Text] [Related]
18. SSR504734, a glycine transporter-1 inhibitor, attenuates acquisition and expression of contextual conditioned fear in rats.
Nishikawa H; Inoue T; Izumi T; Nakagawa S; Koyama T
Behav Pharmacol; 2010 Sep; 21(5-6):576-9. PubMed ID: 20613495
[TBL] [Abstract][Full Text] [Related]
19. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
Maki Y
Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
[TBL] [Abstract][Full Text] [Related]
20. Effect of a dopamine D1/5 receptor antagonist on haloperidol-induced inhibition of the acquisition of conditioned fear.
Inoue T; Izumi T; Li XB; Kitaichi Y; Nakagawa S; Koyama T
Eur J Pharmacol; 2005 Sep; 519(3):253-8. PubMed ID: 16135362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
